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ABSTRACT Escherichia coli are major bacterial pathogens causing bovine mastitis, a
disease of great economic impact on dairy production worldwide. This work aimed
to study the virulence determinants of mammary pathogenic E. coli (MPEC). By
whole-genome sequencing analysis of 40 MPEC and 22 environmental (“dairy-farm”
E. coli [DFEC]) strains, we found that only the fec locus (fecIRABCDE) for ferric dici-
trate uptake was present in the core genome of MPEC and that it was absent in
DFEC genomes (P  0.05). Expression of the FecA receptor in the outer membrane
was shown to be citrate dependent by mass spectrometry. FecA was overexpressed
when bacteria were grown in milk. Transcription of the fecA gene and of the inner
membrane transport component fecB gene was upregulated in bacteria recovered
from experimental intramammary infection. The presence of the fec system was
shown to affect the ability of E. coli to grow in milk. While the rate of growth in milk
of fec-positive (fec) DFEC was similar to that of MPEC, it was significantly lower in
DFEC lacking fec. Furthermore, deletion of fec reduced the rate of growth in milk of
MPEC strain P4, whereas fec-transformed non-mammary gland-pathogenic DFEC
strain K71 gained the phenotype of the level of growth in milk observed in MPEC.
The role of fec in E. coli intramammary pathogenicity was investigated in vivo in
cows, with results showing that an MPEC P4 mutant lacking fec lost its ability to in-
duce mastitis, whereas the fec DFEC K71 mutant was able to trigger intramammary
inflammation. For the first time, a single molecular locus was shown to be crucial in
MPEC pathogenicity.
IMPORTANCE Bovine mastitis is the major infectious disease in dairy cows and the
leading cause of economic loss to the global dairy industry, directly contributing to
the price of dairy products on supermarket shelves and the financial hardships suf-
fered by dairy farmers. Mastitis is also the leading reason for the use of antibiotics in
dairy farms. Good farm management practices in many countries have dramatically
reduced the incidence of contagious mastitis; however, the problems associated
with the incidence of environmental mastitis caused by bacteria such as Escherichia
coli have proven intractable. E. coli bacteria cause acute mastitis, which affects the
health and welfare of cows and in extreme cases may be fatal. Here we show for
the first time that the pathogenicity of E. coli causing mastitis in cows is highly de-
pendent on the fecIRABCDE ferric citrate uptake system that allows the bacterium to
capture iron from citrate. The Fec system is highly expressed during infection in the
bovine udder and is ubiquitous in and necessary for the E. coli bacteria that cause
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mammary infections in cattle. These results have far-reaching implications, raising
the possibility that mastitis may be controllable by targeting this system.
KEYWORDS Escherichia coli, bovine, ferric citrate, mammary gland, mastitis, milk,
pathogenesis, whole-genome sequencing
Bacteria in the species Escherichia coli are a principal causative agent of bovinemastitis (mammary pathogenic E. coli [MPEC]), costing dairy farmers in the Euro-
pean Union an estimated €2 billion per year, with a similar economic burden for the
United States, where each case of mastitis has been estimated to cost $444 (1). The
infection is usually—in upwards of 85% of cases—treated with antimicrobial therapy,
which may contribute to the rise and spread of antibiotic-resistant bacteria (2) as well
as preventing the use of milk from the affected cow in dairy products for several days
following treatment. In addition to the requirement to withhold milk following antibi-
otic usage, there are also long-term alterations in milk quality following episodes of
E. coli mastitis, regardless of the treatment regimen (3). Furthermore, and despite the
use of antibiotics, mastitis carries a substantial risk of mortality or severe morbidity
resulting in culling of the affected animal (4), a factor which adds to the cost of this
disease with respect to the economic and psychological well-being of dairy farmers,
who often form strong emotional attachments with their livestock (5). Clearly, any
management practice or treatment which achieves one or more of the goals of (i)
reducing the incidence of mastitis without contributing to antibiotic resistance, (ii)
reducing the risk of morbidity or mortality following infection, and (iii) reducing the
withholding period for milk to be used in dairy products following treatment will be of
great benefit both to the dairy industry and to consumers.
Iron is a critical micronutrient for the growth of most life-forms, acting as a necessary
cofactor for a variety of enzymes. In bovine milk, much of the iron is bound to various
proteins such as lactoferrin and transferrin; however, milk also contains substantial
concentrations of citrate, which also binds iron with high affinity (6). In fact, the molar
concentration of citrate in milk (approximately 10 mM) greatly exceeds that of other
iron chelating agents (7). To extract iron from milk, it makes logical sense that bacteria
must possess ways to release iron from these chelating agents, and strains of E. coli are
known to encode different complements of such iron acquisition systems (8). These
systems are known to impact the fitness and ability of distinct E. coli strains to cause
other diseases (9). Given the high concentrations of citrate in bovine milk, it is pertinent
that some E. coli strains possess a specific system to capture iron from ferric citrate
(Fe-cit). This system, encoded by the fecIRABCDE locus, binds and translocates Fe-cit at
the outer membrane via FecA and internalizes Fe via FecB, FecC, FecD, and FecE. The
binding of Fe-cit to FecA also transduces a signal, via the response transducer FecR, to
the alternative sigma factor FecI, resulting in upregulation of the fecABCDE genes. FecA
expression has been detected in E. coli strains isolated from mastitis before (10), and
in a recent population level analysis, we identified the Fec system as a core MPEC
determinant for the commonest lineage of E. coli implicated in mastitis (11). In this
study, we experimentally explored the contribution of the Fec system to E. coli mastitis.
RESULTS
The Fec system defined MPEC at the genomic level in a farm-controlled study.
In a recent publication considering MPEC at the population level, we implemented a
novel method to detect genes in the MPEC population which we postulated are critical
for their lifestyle. This method employed defining of genes that were present in the
core genome of MPEC and yet absent in the core genome of closely related strains from
the more widely available E. coli genomic resource. In this way, we detected just three
genetic loci which were core in—and presumably necessary for—MPEC and yet were
not always present in other E. coli strains and therefore were probably not required for
the fitness of E. coli in general (11). Here, we employed a similar analysis; however,
rather than considering close phylogenetic relatives of MPEC, we systematically col-
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lected 62 E. coli samples both from the milk of infected cows and from the dairy farm
environment (dairy farm E. coli [DFEC]). These DFEC samples were collected from the
same farm locales as their MPEC counterparts and represented a highly relevant
comparator group for the MPEC genomes. (Strain information is given in Table S1 in the
supplemental material.) By estimating the pan-genome content of this group of
bacteria, we can detect genes that are present in the core genome of MPEC (defined
as present in at least n  1 of the sample) and yet are not present in the core genome
of DFEC (defined as present in less than n  1 of the sample). In doing so, this analysis
can reveal factors that are ubiquitous in—and potentially necessary for—MPEC and yet
are not strictly necessary for the survival of E. coli in the dairy farm environment. This
analysis yielded the identification of just 45 genes which met these criteria (Fig. 1).
FIG 1 Presence/absence diagram showing the distribution of 45 genes identified as the specific core MPEC genome alongside the phylogenetic relationships
between the strains. Phylogeny data are based on maximum likelihood inferences of nucleotide sequences for genes shared by all strains (1,000 bootstrap
replicates, 2,838,669 alignment positions). Data representing bootstrap support for nodes below 90% are labeled. Phylogroup assignments are inferred from
a larger tree comprising 4,022 E. coli genome sequences (shown in Fig. S1). Genes with statistically significant association with MPEC (corrected P  0.05) are
indicated with an asterisk. K71—used in this work—is highlighted with an asterisk next to its name.
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Subsequently, by employing Fisher’s exact test to determine which of these genes were
significantly more likely to be found in MPEC than in DFEC, we determined that just 8
genes achieved statistical significance (adjusted P  0.05). These genes included the 7
coding sequences for the fec locus (fecIRABCDE) along with an adjacent gene, yghV,
which forms part of the KpLE2 phage-like element which can mobilize the fec genes,
even between different species of bacteria (12). The locus fecIRABCDE was absent in
only one MPEC strain in our panel.
Expression of the Fec system is induced in milk in vitro and in vivo. The strong
correlation seen with regard to the presence of fecIRABCDE in MPEC genomes
prompted us to investigate the expression of the Fec system during the infection
process. The ability of E. coli to grow in milk is highly correlated with the ability to cause
mastitis (13, 14), and so to explore this hypothesis, we employed a proteomic approach
to validate the production of FecA during growth in milk in vitro and a transcriptional
approach to investigate the expression of fecA and fecB in vivo. In our in vitro experi-
ment, we grew prototypical MPEC strain O32:H37 P4 in Dulbecco’s modified Eagle’s
medium (DMEM) with and without the addition of citrate, and in ultra-heat-treated
(UHT) milk, and investigated the proteins present in the outer membrane (OM) of the
bacteria by mass spectrometry. These data show that the OM protein FecA could not
be identified following growth in DMEM without the addition of citrate (0 peptides).
With the addition of 0.1 mM citrate, we could identify 10 peptides covering 20.3% of
the FecA protein sequence. With the addition of 10 mM citrate, we could identify 50
peptides, covering 67.2% of FecA, and following growth in milk we could identify 63
peptides, covering 76% of the FecA protein sequence. These data are presented in
Fig. 2A as a function of the total number of peptides identified in the OM preparations.
Remarkably, in UHT milk, peptides from FecA constituted almost 5% of the total
number of identified OM peptides. The use of 10 mM citrate in this experiment reflects
the concentration of citrate found in milk (7). The list of all proteins identified is
presented in Table S2. In our in vivo experiment, we experimentally infected cows with
MPEC strain P4 and measured the transcript level of the outer membrane receptor gene
fecA and the inner membrane transport component gene fecB by reverse transcription-
quantitative PCR (RT-qPCR) in bacteria recovered from the milk at 6 h postinfection. We
FIG 2 Fec system products and genes are upregulated in milk in vitro and in vivo. (A) Outer membrane (OM) protein
preparations from MPEC strain P4 following growth in DMEM with or without citrate (cit) or UHT milk, showing citrate-
dependent expression of FecA in the OM, with maximum expression achieved in milk. This experiment was performed once.
(B) Transcription of fecA or fecB measured by RT-qPCR following growth in laboratory media (LB and DMEM) or following
growth in vivo in the udders of experimentally infected cows relative to transcription of the control 16S and frr genes. Points
represent biological replicates.
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compared the levels of transcription of these genes to those observed in standard
laboratory medium (DMEM or LB) (Fig. 2B). The data showed a clear upregulation of the
fecA and fecB genes in the milk of experimentally infected cows relative to the results
seen with standard laboratory media. Together, these data provide strong evidence
that FecA is expressed and, given that our proteomic data were derived from an OM
preparation, that it is localized to the outer membrane during growth in milk in vitro
and that MPEC strains employ the Fec system in vivo in cows during the infection
process.
The Fec system is essential for growth in milk and for experimental mastitis.
Considering the clear upregulation of Fec system genes and products induced by milk
in vitro and in vivo, we requeried our previously published data on the ability of
wild-type (WT) E. coli to grow in milk (13) with additional WT DFEC and MPEC isolates
and discovered a good correlation between carriage of the fecIRABCDE locus and the
ability of E. coli to support high levels of growth in milk (see Fig. S2 in the supplemental
material). These data represent compelling circumstantial evidence that the Fec system
is a key driver of the MPEC phenotype. To investigate further, we took two comple-
mentary approaches. First, we deleted the fecIRABCDE genes in MPEC strain P4 (P4
ΔfecIRABCDE), which has previously been well documented to grow well in milk and
elicit mastitis (14). Second, we introduced the fecIRABCDE locus in trans into environ-
mental isolate K71 (K71fecIRABCDE), a strain which has been previously shown to be
unable to grow to high levels in milk and to be incapable of eliciting experimental
mastitis in mice (14) and cows (15).
We investigated the ability of these strains to grow in milk. Figure 3A shows that in
the absence of the Fec system, P4 suffered a four-log reduction in the number of cells
generated over 8 h of growth. The level of growth of the wild-type K71 strain in milk
was comparable to that seen with the P4 ΔfecIRABCDE strain. In contrast, the
K71fecIRABCDE strain showed an approximately five-log increase in biomass (mea-
sured by CFU) following 8 h of growth in milk and grew to levels comparable to those
seen with the P4 wild-type strain. These data show that the presence of the fecIRABCDE
genes is pivotal in allowing E. coli to grow in milk. The levels of growth of these strains
were highly comparable following culture in standard laboratory media (Fig. S3).
Following from this, we used these strains in experimental infections in cows to
investigate if dependence on fecIRABCDE for growth in milk translated to an effect on
the incidence of mastitis in vivo. Over a time course, we collected milk from the udders
of infected cows and profiled the number of viable E. coli bacteria by CFU (Fig. 3B) and
the number of intramammary leukocytes (Fig. 3C) or neutrophils (Fig. 3D) by flow
cytometry. Our results indicate that fecIRABCDE provides a major advantage with
respect to the ability of E. coli to colonize and grow in the mammary gland and that the
presence of that locus appears to be an absolute requirement. In the absence of
fecIRABCDE, the P4 ΔfecIRABCDE strain and the wild-type K71 strain were not detectable
by CFU analysis at any time point during our investigation. In contrast, both the
wild-type P4 and K71fecIRABCDE strains grew to substantial levels in the udders of
cows during our experimental infection. There was an observable difference between
these two fecIRABCDE-positive strains in the levels of growth, with the K71fecIRABCDE
strain not achieving the same biomass as wild-type P4 and appearing to be cleared
more rapidly. For this reason, the stability of the Fec plasmid construct in transformed
K71 was tested in batch culture in milk over a period of 36 h, in order to span the time
period when a decrease of K71 Fec mutants was observed in vivo. No significant
difference in the numbers of chloramphenicol-resistant (K71 Fec transformants) or
total E. coli cells was observed in vitro. Thus, the plasmid appears to have remained
stable in the overall population of K71 transformants and other factors may have played
a role in bacterial clearance. Other genomic and phenotypic distinctions between E. coli
strains K71 and P4 which may have contributed remain speculative and subject to
separate systematic investigation.
Despite the difference in growth levels, there were broad similarities in the
numbers of immune cells such as leukocytes (Fig. 3C) and neutrophils (Fig. 3D)
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infiltrating the milk following infection with either the wild-type P4 strain or the
K71fecIRABCDE strain, indicating that an inflammatory process was evoked by
both strains, as such increases in immune cell infiltration into milk are typical of
mastitis, although variable (16). In contrast, both of the fecIRABCDE-negative strains
(P4 ΔfecIRABCDE and wild-type K71) were defined by the presence of a considerably
lower level of immune cell infiltration than was seen with their fecIRABCDE-positive
counterparts, suggesting that neither strain elicited an inflammatory response in
the challenged mammary glands. These infection studies showed that Fec substan-
tially enables fitness, promoting growth and allowing intramammary infection and,
consequently, mastitis.
FIG 3 E. coli bacteria are dependent on fecIRABCDE for growth in milk and to elicit mastitis in cattle. (A) Growth
in milk in vitro of fecIRABCDE-positive strains, the wild-type P4 strain (P4 WT), the K71 strain with introduction of
fecIRABCDE (K71fec mutant), and fecIRABCDE-negative strains (P4 Δfec mutant and K71 WT). Introduction of the
fec locus in K71 alone allowed growth in milk similar to that seen with MPEC P4. Deletion of the fec locus in P4
impaired growth in milk in a manner similar to that seen with the K71 WT strain naturally lacking fec. (B) Recovery
of E. coli in milk of experimentally infected cows, showing an absolute requirement for fecIRABCDE to permit growth
in the mammary gland in vivo. Strains lacking the fec locus (P4 Δfec and K71 WT) were not detectable at any time
point following intramammary infusion of bacteria (time zero), in contrast to the fecIRABCDE-positive strains (P4 WT
and K71fec). (C and D) Measurement of leukocytes (C) and neutrophils (D) as a function of total somatic cell
counts (SCC) in the milk of challenged animals, showing that infection with fecIRABCDE-positive strains (P4 WT or
K71fec) led to a considerable influx of immune cells into the milk, coincident with symptoms of clinical mastitis.
In the absence of fecIRABCDE (P4 Δfec or K71 WT), levels of infiltration of immune cells into the milk were
significantly lower, and no symptoms of mastitis were observed. Solid lines represent mean values, while the
surrounding colored polygons represent standard deviations.
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DISCUSSION
In this paper, we present for the first time powerful evidence for the significant
contribution of the Fec iron-citrate uptake system as a highly significant genetic
determinant for the ability of E. coli to successfully cause intramammary infection and
thus to elicit mastitis. Here, we show that the Fec system is a prerequisite for the
pathogenicity of E. coli in the mammary gland, as the prototypical MPEC strain P4
is incapable of eliciting mastitis in its absence and the demonstrably non-mammary
gland-pathogenic K71 strain gains MPEC capability with its addition. Although the
fec-positive strains grew at comparable levels in milk in vitro, there were clear differ-
ences in the level of biomass achieved by the K71fecIRABCDE strain relative to that
achieved by the wild-type P4 strain in vivo. This lower growth capacity in vivo, which is
unlikely to have resulted from the loss of the plasmid carrying fecIRABCDE (for which we
did not find any evidence), may be presumed to improve efficiency of bacterial cell
washout through milking, which could exacerbate fitness deficiencies in the K71
transformant population. Nonetheless, the bovine udder is an environment that, in the
absence of fecIRABCDE, strain K71 has not previously been found to be able to exploit.
This locus provides functional capability that retrieves this strain from an inherent
fitness deficit in intramammary colonization and growth. Therefore, we consider it is
likely that MPEC strains, exemplified by P4, are highly adapted for selection, coloniza-
tion, and growth in the bovine udder, a capability to which Fec makes a substantive
contribution.
Previous studies by us and others showed that E. coli consistently carried the
high-affinity enterobactin iron acquisition system, and this is the case with both P4 and
K71 strains. In fact, K71 also possesses a locus encoding aerobactin (frequently asso-
ciated with extraintestinal E. coli but not with mastitis strains); hence, an inability to
acquire iron by systems other than Fec cannot predicate the differences between P4
and K71 strains. We postulate that the presence of selective pressure with respect to
the ability of P4 to successfully compete in bovine milk has resulted in a strain which
is considerably more fit in this niche than the K71fecIRABCDE strain. For instance, K71
was shown to be less resistant than typical MPEC to phagocytosis and killing by
leukocytes in vitro, which could have contributed to faster clearance of this strain in the
mammary gland, after the onset of mastitis (which is accompanied by significant levels
of inflammatory cell influx) (13). Overall, our data indicate that the fecIRABCDE genes
provide E. coli with a necessary “foot in the door” to bovine mastitis, allowing the
possibility that the bacteria would establish in and adapt to this niche, rather than
being excluded a priori.
The inflammatory reaction in the mammary gland is triggered by microbe-
associated molecular patterns (MAMPS) of E. coli. The best characterized is that seen
with lipopolysaccharide (LPS) (endotoxin), which, when infused alone in the mammary
gland, causes an inflammatory reaction resembling actual E. coli infection although
shorter in duration. Other E. coli MAMPs were shown to also play a role in triggering
inflammation in the gland (17), although LPS is the most highly potent. Factors that
improve E. coli fitness in the gland milieu, allowing some strains to be better adapted
to this niche, appear to affect pathogenicity. For example, some strains have been
shown to be able to invade mammary epithelial cells, with this ability being associated
with E. coli causing persistent infections (18).
The genome of strain K71 harbors various virulence-associated factors, such as the
type VI secretion system, type IV pilus, fimbriae, and curli adhesins, some of which have
also been described in MPEC (14, 19, 20). Also, although lacking the Fec cluster, strain
K71 has in common with MPEC (including P4) the iron uptake systems enterobactin and
efeUOB and also has aerobactin, which is uncommon among MPEC strains but common
among extraintestinal pathogenic E. coli (ExPEC) strains (20). Thus, in terms of virulence-
associated gene content, strain K71 has other determinants associated with potential
pathogenicity and yet cannot elicit mastitis in the absence of the Fec locus. Therefore,
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it is expected that presumptive virulence factors of E. coli K71 play roles in colonizing
the bovine udder, albeit with the Fec system playing a preemptive role.
We conclude that the Fec system is essential to confer to E. coli the ability to cause
mastitis. We propose that, without Fec, E. coli cannot multiply in the bovine milk in the
mammary gland sufficiently to allow establishment of an actual infection and conse-
quent triggering of inflammation. E. coli mastitis is often considered to be “environ-
mental” in origin, and this is supported by our observation that some DFEC strains carry
fecIRABCDE and can grow in milk to levels comparable to those seen with MPEC. We
consider it likely that MPEC strains are selected from fecIRABCDE-carrying E. coli present
in the environment. It is debatable whether the Fec system should be considered a
virulence factor or a fitness factor in this context and, consequently, whether it defines
MPEC as an E. coli pathotype or as an ecotype. In contrast to the intestinal milieu, where
a variety of nonpathogenic strains may exist, the mammary gland is normally devoid of
any E. coli bacteria, and there are no “mammary commensal” strains. In this niche, E. coli
bacteria possessing the Fec locus have a fitness advantage which facilitates adaptation
and growth in this milieu. Together with this capability, there are further fitness and
virulence determinants which contribute to characteristics such as resilience with
respect to host antimicrobial defenses and, of course, the major contribution from
endotoxin as bacterial numbers rise. These characteristics show similarities with phy-
logenetically distinct extraintestinal pathogenic E. coli (ExPEC) strains such as uropatho-
genic E. coli (UPEC). Like MPEC, to date, no single essential virulence factor has been
defined in ExPEC but, rather, a suite of systems (some more important than others), all
enabling colonization of the urinary tract or other extraintestinal sites, has been
described (8). Also similarly to MPEC, many E. coli also harbor those same systems, and
yet it is the ability of ExPEC to utilize them outside the gut, and particularly in the
urinary tract or in blood circulation, that allows pathogenicity in this specific site. This
supports the definition of MPEC as a distinct clade among ExPEC.
Our data represent a validation of the postgenomics method and set an example for
how comprehensive population-level genomic analyses can reveal crucial factors which
underpin the ability of bacteria to cause complex infections. Further study is needed to
investigate how this new information on the role of the Fec system in MPEC can be
explored to provide novel effective management strategies or efficacious treatments
for mastitis. Interestingly, Klebsiella pneumoniae bacteria, specifically, those isolates
collected from cows with mastitis, also carry the fecIRABCDE locus (10, 21), suggesting
that our results reported here on the importance of citrate and ferric citrate sensing
mechanisms may have extended relevance for other mastitis-causing organisms.
MATERIALS AND METHODS
Ethics statement. The animal experiments received approval from the Ethics Committee of Val de
Loire, France (DGRI’s APAFIS agreement no. 813-2015061109103810v2), and were compliant with all
applicable provisions established by European directive 2010/2063/UE (bovine intramammary challenge
for RT-qPCR) or were approved by the ARO Committee of Animal Experimentation and adhered to
stipulated ethical and safety guidelines (bovine intramammary challenge for pathogenicity assay).
Isolation of E. coli strains and genome sequencing. E. coli isolates were collected and identified as
described before (13, 22). MPEC (mammary pathogenic E. coli) isolates were collected from mammary
glands of cows with clinical mastitis. MPEC samples were selected only from cultures with clear E. coli
growth, without contaminants, and at least two consecutive cultures were performed to confirm E. coli
etiology in mastitis cases. DFEC (dairy farm E. coli) strains were isolated from different places in the
cowshed in the same farms and during the same periods of time as the MPEC strains.
Bacteria were grown in blood agar overnight. Total DNA was extracted from each of the isolates
using a MasterPure DNA purification kit (Epicentre, Madison, WI) per the manufacturer’s instructions.
Sequencing was performed using an Illumina MiSeq sequencer at Glasgow Polyomics, Wolfson Wohl
Cancer Research Center, Glasgow, United Kingdom, as previously described (11).
E. coli pan-genome estimation. The pan-genome structure of the E. coli genome sequences was
estimated as described recently (11). Briefly, the genes for the 62 E. coli isolates used in this study were
predicted by Prodigal (23). A preclustering step was carried out, via iterative NUCmer alignments of
successive genomes to the pan-genome, to assemble a bank of genes that shared less than 95%
sequence similarity (an average of percent sequence identity and percent matching length). A clustering
step was then carried out (via NUCmer) to identify gene families which shared less than 80% sequence
similarity. These data were transposed to a presence/absence matrix for further investigation. We
extracted genes that were part of the core MPEC genome (defined as present in at least n  1 genomes)
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and yet were not part of the DFEC core genome (defined as absent in at least n  1 genomes) and
investigated the difference in carriage between MPEC and DFEC by Fisher’s exact test. We corrected the
resulting P values for multiple tests using the Hochberg method implemented using the “p.adjust”
function within R.
E. coli phylogenetic analysis. The structure of the pan-genome was explored to identify genes
present in all strains. This resulted in the identification of 3,218 genes. The nucleotide sequences for these
genes were aligned by Muscle (24) and concatenated, and then poorly aligned regions were eliminated
using Gblocks (25). The resulting 2.8-Mbp alignment per sequence was used to build a maximum
likelihood tree using RAxML (26) under the GTR model with 1,000 bootstrap replicates. Our population
analysis of 4,022 E. coli genomes was carried out as described in a recent publication (27).
Generation of fecIRABCDE gene deletions in E. coli P4. A nonpolar gene deletion of the fec locus
was generated using the Lambda Red-mediated recombination method (28). Briefly, template plasmid
pKD4 (conferring kanamycin resistance [kanamycinr]) was used to amplify the corresponding resistance
cassette with primers containing flanks directly adjacent to the fec locus (Table S3). PCR products were
purified by phenol-chloroform extraction, ethanol precipitation, and DpnI treatment to concentrate the
template and maximize the efficiency of the recombination reaction. E. coli P4 carrying pKD46 was
cultured to an optical density (OD) of 0.4 in super optimal broth (SOB) at 30°C and induced with 10 mM
arabinose 1 h prior to being made electrocompetent by washing and 1:100-fold dilution in ice-cold 10%
glycerol. Cells were then transformed with 1 g of template per 50 l and recovered for 2 h at 37°C in
super optimal broth with catabolite repression (SOC) before plating on selective media was performed.
Recombinants were selected for on LB agar containing 40 g/ml kanamycin. Phenotypically positive
colonies were screened for resistance cassette recombination by PCR. Removal of template resistance
cassettes was performed by the use of a temperature selection shift from 30°C to 37°C on plain LB media
using plasmid pCP20 (ampicillinr). Removal of the fecIRABCDE locus was confirmed by PCR.
Construction of the fecIRABCDE plasmid and K71 transformation. Complementation of the fec
locus mutant was achieved by expression of fecIRABCDE from its natural promoter on a modified
pACYC184 backbone. The complementation plasmid was constructed using the NEBuilder protocol (New
England Biolabs). Briefly, pACYC184 was linearized by PCR to create a blunt end backbone (2,755 bp)
lacking the tetracycliner gene. Two fragments corresponding to the two halves of the fecIRABCDE locus
plus an additional 200 bp from either side (4,003 bp and 3,867 bp, respectively) were also amplified by
PCR using primers that created unique orientation-specific overhangs for assembly of both halves on the
backbone of pACYC184. Primers were designed using the NEBuilder design module, and the design
strategy for assembly was confirmed using MacVector version 12.5. PCR fragments were purified by gel
extraction and used in a one-step assembly reaction according to the NEBuilder kit manufacturer’s
protocol. Reaction mixtures were transformed and selected on LB agar containing 20 g/ml chloram-
phenicol. Positive clones were confirmed by PCR and digestion with EcoRV. The construct contained a
unique EcoRV restriction site, yielding a 10,625-bp linearized fragment. A table of the primer sequences
used is presented in Table S4.
K71 was transformed with fecIRABCDE plasmid construct by electroporation. Chloramphenicol-
resistant clones were compared to wild-type K71 by enterobacterial repetitive intergenic consensus-PCR
(ERIC-PCR) (29) and plasmid profiling (30) to confirm their identification.
Proteomics. E. coli strain P4 was grown in DMEM (Sigma) overnight and inoculated at an OD600 of
0.001 and then grown for 6 h aerobically at 37°C under static conditions in (i) DMEM; (ii) DMEM
supplemented with 0.1, 1.0, or 10 mM citric acid; or (iii) UHT milk. DMEM cultures were supplemented
with 100 mM HEPES (pH 7.2). Outer membrane proteins were prepared via Sarkosyl extraction and
analyzed via shotgun proteomics as previously reported (31).
Milk growth experiments. The rate of growth in milk was tested as described before (14). Briefly,
bacteria were harvested from overnight growth on blood agar, or on LB agar supplemented with
chloramphenicol for strain K71fecIRABCDE, and washed with phosphate-buffered saline (PBS). The
bacterial concentration was assessed by calculation of the level of turbidity against a previously prepared
concentration  the OD curve and was normalized to approximately 2  103 CFU/ml. Fresh bovine milk
was collected 1 day prior to the experiment, pasteurized at 80°C for 10 min, and tested for sterility by
culture on blood agar. A 100-l volume of bacterial suspension was inoculated in 40 ml of milk, and the
mixture was incubated at 37°C. Samples were aseptically collected for CPU determinations at 4 and 8 h.
Experiments were conducted up to four times separately, with two replicates per experiment. The
numbers of data points per time point were 8 (P4 WT strain), 6 (strain P4 Δfec and strain K71 WT), and
4 (strain K71fec). The stability of the Fec plasmid construct in transformed strain K71 was tested in vitro
in a batch milk culture of this mutant grown up to 36 h. In this experiment, to check for any growth of
K71 that was independent of the plasmid, bacterial counting was performed on agar with and without
chloramphenicol. P4 WT and K71 WT were used as positive (high-growth) and negative (lower-growth)
controls.
Bovine intramammary challenge for RT-qPCR. Four Holstein-Frisian cows were challenged as
previously described (32). At 8 h postinoculation, 50 ml collected milk was mixed with 100 ml RNAProtect
(Qiagen). The suspension was incubated at room temperature for 5 min and then centrifuged for 20 min
at 5,000  g. The supernatant was discarded and the pellet stored at 20°C. Prior to RNA extraction, the
pellet was thawed on ice and resuspended in 1 ml of Trizol reagent. The suspension was transferred to
a 2-ml Lysing Matrix B tube (MP Biomedicals) and shaken for 45 s at speed 6 in a FastPrep 24 apparatus
(MP Biomedicals). A 200-l volume of chloroform was added to each tube. After 5 min at room
temperature, tubes were centrifuged for 15 min at 12,000  g at 4°C. The aqueous phase was collected,
mixed with an equal volume of 70% ethanol, and loaded onto a NucleoSpin RNA column (Macherey-
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Nagel). RNA was then extracted according to the manufacturer’s instructions with on-column DNase 1
treatment. RNA extraction from in vitro cultures was performed using E. coli P4 grown overnight in a
static culture at 37°C in DMEM or LB broth.
Approximately 100 ng of RNA was converted to cDNA using iScript Reverse Transcription Supermix
(Bio-Rad). Quantitative PCR was then performed using iQ SYBR green Supermix (Bio-Rad) and primers for
fecA (F, AACGCCAACGCTTGATAACG; R, AGCGTGCCTTTATGTTTCGG) or fecB (F, ACATCGCCTTGCAGCAA
ATC; R, ACCATTTCGCCGATGATAGC). Quantification was performed using expression levels of the 16S
gene (F, GTTAATACCTTTGCTCATTGA; R, ACCAGGGTATCTAATCCTGTT) and frr (F, TGGACAAATGCGTAGA
AGCG; R, ATTCCACGACAATGCCATCC) as the reference genes, alongside the Genex macro (Bio-Rad).
Bovine intramammary challenge for pathogenicity assay. Intramammary challenge was per-
formed in Holstein cows. All mammary glands used were free of infection based on three consecutive
negative bacteriologic examinations and a milk somatic cell count (SCC) level of lower than 100,000 cells/
ml. Inocula were prepared by harvesting bacteria from a culture grown overnight on blood agar
(P4ΔfecIRABCDE) or on LB agar containing chloramphenicol (K71fecIRABCDE). Bacteria were washed in
pyrogen-free saline (PFS), and quantification of viable bacteria was estimated by optical density and
confirmed by plate counting. The inoculum was stored at 4°C for 10 h. The bacterial cell number was
adjusted using PFS just before challenge to yield an inoculum of approximately 100 CFU/ml and was
confirmed by plate counting. Before morning milking (time zero), a milk sample was taken from each
gland. After milking, teats were cleaned and disinfected with iodine and antiseptic cloths, and the
inoculum was injected through the teat canal using sterile syringe mounts for intramammary injection.
Cows were observed, including rectal temperature measurements, for 48 h for clinical signs of mastitis.
Strains K71fecIRABCDE and P4ΔfecIRABCDE were inoculated into glands from seven cows in total.
Strains were inoculated into contralateral glands in four animals, whereas strain K71fecIRABCDE was
inoculated into a single gland in one animal and strain P4ΔfecIRABCDE was inoculated into a single gland
in two animals. Due to the constraints imposed by the high cost of animal challenges, control data for
strains P4 and wild-type K71 were taken from previous work (15). We state explicitly that these strains
were not used concurrently with their respective mutants; however, the experiments were conducted
identically.
Samples of milk from challenged glands were collected before milking and after 8, 16, 24, and 48 h.
Teats were cleaned and disinfected, and foremilk was discarded. A sample of 3 ml of milk was collected
aseptically into sterile tubes for bacteriologic culture. To detect contaminants, bacteriologic culture was
performed by plating 100 l of milk on blood agar. E. coli counting was performed on MacConkey agar
by CFU counting, following serial dilutions of milk with saline solution. Approximately 200 ml of milk was
then collected for SCC determinations, and differentiation of leukocytes was evaluated as described
previously (3).
Accession number(s). Genome sequences were uploaded to NCBI under the accession numbers
given in Table S1. The NCBI BioProject accession number for this study is PRJNA341825.
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